These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1185911)

  • 1. The classification and treatment of essential hypertension using the renin-sodium index for vasoconstriction-volume analysis.
    Laragh JH
    Johns Hopkins Med J; 1975 Oct; 137(4):184-94. PubMed ID: 1185911
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease.
    Laragh JH; Baer L; Brunner HR; Buhler FR; Sealey JE; Vaughan ED
    Am J Med; 1972 May; 52(5):633-52. PubMed ID: 4337477
    [No Abstract]   [Full Text] [Related]  

  • 3. The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hypertension.
    Laragh JH; Sealey JE; Niarchos AP; Pickering TG
    Fed Proc; 1982 Jun; 41(8):2415-23. PubMed ID: 7084486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens and hypertension: effect of discontinuing estrogens on blood pressure, exchangeable sodium, and the renin-aldosterone system.
    Crane MG; Harris JJ
    Am J Med Sci; 1978; 276(1):33-55. PubMed ID: 45830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Essential hypertension: Renin and aldosterone, key to pathogeny and therapy?].
    Bühler FR
    Schweiz Med Wochenschr; 1974 Jul; 104(29):1013-22. PubMed ID: 4153738
    [No Abstract]   [Full Text] [Related]  

  • 6. The renin system in essential, renovascular and adrenocortical hypertension: an overview.
    Laragh JH
    Adv Nephrol Necker Hosp; 1977; 7():157-89. PubMed ID: 96672
    [No Abstract]   [Full Text] [Related]  

  • 7. Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition.
    Hollenberg NK; Williams GH
    J Hypertens Suppl; 1983 Oct; 1(1):119-28. PubMed ID: 6100600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK; Williams GH
    Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
    [No Abstract]   [Full Text] [Related]  

  • 9. Recognizing and treating two types of long-term vasoconstriction in hypertension.
    Laragh JH; Resnick LM
    Kidney Int Suppl; 1988 Sep; 25():S162-74. PubMed ID: 3054233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology of hypertension].
    Lydtin H
    Z Allgemeinmed; 1975 Nov; 51(33):1511-8. PubMed ID: 1108461
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative analysis of the pathophysiology of hypertension.
    Guyton AC; Coleman TG
    Circ Res; 1969 May; 24(5 Suppl):1-19. PubMed ID: 4306217
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy].
    Nast HP; Philipp T
    Fortschr Med; 1974 Apr; 92(11):447-51. PubMed ID: 4362672
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
    Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
    Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral factors in the pathogenesis of primary hypertension.
    Zidek W; Heckmann U; Lange-Asschenfeldt H; Losse H; Vetter H
    Klin Wochenschr; 1985; 63 Suppl 3():94-6. PubMed ID: 4039777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of a low sodium diet on the functional state of the central nervous system, kidneys and adrenals of patients with hypertension].
    Trangeĭzer VA; Labeeva TN; Morozova VA
    Vopr Pitan; 1971; 30(4):32-8. PubMed ID: 5141598
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral contraceptives and arterial hypertension].
    Losse H; Risse E; Wessels F
    Med Klin; 1974 Dec; 69(50):2043-50. PubMed ID: 4374645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renin and aldosterone in human arterial hypertension (excluding Conn's syndrome)].
    Veyrat R; Genest J; Tremblay G; Boucher R; de Champlain J
    Pathol Biol; 1965 Nov; 13(21):1086-93. PubMed ID: 4299263
    [No Abstract]   [Full Text] [Related]  

  • 20. [Etiology and pathogenesis of hypertension].
    Ledingham JM
    Internist (Berl); 1974 Mar; 15(3):114-23. PubMed ID: 4365782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.